Chronos Archive seal
The Human Record

Judy Garland

Case HR-ML005-TD · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
June 10, 1922 – June 22, 1969
Synthetic DOB
1922-06-10
Index visit
1955-06-22 at age 33
Synthetic MRN
HR-ML005-SYN-TD

Teaching objective: Iatrogenic dependence and the duty to prescribe controlled drugs safely, especially to minors: nonjudgmental primary care for a 33-year-old singer and actor, three months after childbirth, who has taken prescribed barbiturate sleeping pills and amphetamine since she was a teenager. The episode covers a DSM-5-TR assessment that does not count tolerance and withdrawal from supervised use, the DAST-10, a prescription drug monitoring program review, one prescriber and limited dispensing, a supervised hospital change to phenobarbital because barbiturate withdrawal can cause seizures, a slow outpatient taper that follows the tapering principles of the 1954 Joint Clinical Practice Guideline on Benzodiazepine Tapering (which excludes barbiturates) with addiction medicine guidance, a short stimulant taper, CBT for insomnia as first-line treatment instead of another hypnotic, depression and anxiety care with a structured safety assessment, means safety and the 988 Suicide & Crisis Lifeline, contraception that phenobarbital does not weaken, nutrition and weight without stigma, the reason naloxone was not prescribed, and planning around the demands of performing.

Historical timeline

DateEventClaims
June 10, 1922Born Frances Ethel Gumm in Grand Rapids, Minnesota.CLM-0001
1935Signed by Metro-Goldwyn-Mayer at 13.CLM-0002
1939A national star at 17 in The Wizard of Oz; by then taking stimulant and sleeping pills given to her as a teenage performer.CLM-0002, CLM-0003, CLM-0004
1949Hospital stay in Boston; treated for what was publicly called exhaustion.CLM-0007, CLM-0005
1950Studio contract ended; a suicide attempt was reported publicly; return to the stage in concert.CLM-0006, CLM-0008
1954A Star Is Born released; Academy Award nomination.CLM-0009
March 1955Birth of her third child.CLM-0010
September 24, 1955Television debut on the first Ford Star Jubilee broadcast.CLM-0011
1959Hospitalized with acute hepatitis.CLM-0012
June 22, 1969Died in London at 47; the coroner ruled the death an accidental barbiturate overdose.CLM-0013

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Judy Garland was born Frances Ethel Gumm on June 10, 1922, in Grand Rapids, Minnesota, to parents in vaudeville, and first appeared on stage as a small child. confirmed Powers N. Garland, Judy (1922-1969). Women in World History: A Biographical Encyclopedia (Gale) supports
Milestones, Jun. 27, 1969 supports
5 Interesting Facts About Judy Garland supports
Haynes S. The True Story Behind Judy, the New Film Based on Judy Garland's Life supports
HISTMED Master Roster v3 context
D She was signed by Metro-Goldwyn-Mayer at 13 and became a national star at 17 in The Wizard of Oz.
Anchors her work as a performer from childhood and the studio years in the modern social history.
confirmed 5 Interesting Facts About Judy Garland supports
Milestones, Jun. 27, 1969 supports
Haynes S. The True Story Behind Judy, the New Film Based on Judy Garland's Life supports
D As a teenage studio performer she was given stimulant "pep pills" (amphetamines; Benzedrine is named) to suppress her appetite and keep up her energy through long working days, and sleeping pills (barbiturates; Seconal is named) so that she could sleep. She later described being given pills to stay on her feet and then being put to sleep with sleeping pills at the studio hospital.
The anchor for the synthetic sedative-hypnotic and stimulant use disorders and for the teaching point: dependence that began with drugs given to a minor by adults with power over her. Recorded without blame.
confirmed Bertram C. Judy Garland Filmed The Wizard of Oz Under Grueling Conditions supports
Blakemore E. Golden Age Hollywood Had a Dirty Little Secret: Drugs supports
Haynes S. The True Story Behind Judy, the New Film Based on Judy Garland's Life supports
Powers N. Garland, Judy (1922-1969). Women in World History: A Biographical Encyclopedia (Gale) supports
R Accounts differ on who first gave her the pills. A biography by Gerald Clarke reports that her mother gave her pills for energy and sleep in early childhood, before she joined the studio; other accounts attribute the pills to the studio and its doctors.
Recorded only to show that the account of how her dependence began is contested; the episode relies on the documented fact that the pills were given to her as a minor, not on who began it.
disputed Bertram C. Judy Garland Filmed The Wizard of Oz Under Grueling Conditions supports
Review of Clarke G. Get Happy: The Life of Judy Garland supports
Blakemore E. Golden Age Hollywood Had a Dirty Little Secret: Drugs supports
Blakemore E. Golden Age Hollywood Had a Dirty Little Secret: Drugs disputes
D She struggled with dependence on prescribed medicines, stimulants and sleeping pills, for the rest of her life; by her twenties she was already dependent on pills.
The anchor for long-term dependence in the modern episode.
confirmed Powers N. Garland, Judy (1922-1969). Women in World History: A Biographical Encyclopedia (Gale) supports
Review of Clarke G. Get Happy: The Life of Judy Garland supports
Bertram C. Inside Judy Garland's Final Years and Her London Concerts supports
D Suicide attempts were reported publicly, including one in 1950; a biographical encyclopedia describes others in the 1940s and early 1950s.
History only, without detail. In the modern episode it is a historical risk factor in the structured safety assessment.
confirmed Milestones, Jun. 27, 1969 supports
Powers N. Garland, Judy (1922-1969). Women in World History: A Biographical Encyclopedia (Gale) supports
Review of Clarke G. Get Happy: The Life of Judy Garland supports
D In her twenties she was treated for what was publicly called exhaustion and spent periods in hospitals and sanitariums, including a stay at Peter Bent Brigham Hospital in Boston in 1949.
History only, without detail.
confirmed Review of Clarke G. Get Happy: The Life of Judy Garland supports
Powers N. Garland, Judy (1922-1969). Women in World History: A Biographical Encyclopedia (Gale) supports
D Her contract with Metro-Goldwyn-Mayer ended in 1950, and she returned to the stage in concert. confirmed Powers N. Garland, Judy (1922-1969). Women in World History: A Biographical Encyclopedia (Gale) supports
Haynes S. The True Story Behind Judy, the New Film Based on Judy Garland's Life supports
Milestones, Jun. 27, 1969 supports
D She starred in A Star Is Born, released in 1954, and was nominated for the Academy Award for Best Actress.
Anchors her film work in the year before the modern episode.
confirmed Milestones, Jun. 27, 1969 supports
Haynes S. The True Story Behind Judy, the New Film Based on Judy Garland's Life supports
Powers N. Garland, Judy (1922-1969). Women in World History: A Biographical Encyclopedia (Gale) supports
D She gave birth to her third child, a son, in March 1955.
Anchors the postpartum timing of the modern episode; the child is not named.
confirmed Powers N. Garland, Judy (1922-1969). Women in World History: A Biographical Encyclopedia (Gale) supports
D On September 24, 1955, she made her television debut on the first Ford Star Jubilee broadcast.
History after the index visit.
confirmed TV Guide, Philadelphia edition, September 24, 1955 (Media History Digital Library) supports
D In 1959 she was hospitalized with acute hepatitis and liver disease.
History after the modern episode; the episode records no liver disease.
confirmed Haynes S. The True Story Behind Judy, the New Film Based on Judy Garland's Life supports
Powers N. Garland, Judy (1922-1969). Women in World History: A Biographical Encyclopedia (Gale) supports
D She died in London on June 22, 1969, at 47; the coroner ruled her death an accidental overdose of barbiturates.
History only, recorded in one plain sentence.
confirmed Bertram C. Inside Judy Garland's Final Years and Her London Concerts supports
Haynes S. The True Story Behind Judy, the New Film Based on Judy Garland's Life supports
Powers N. Garland, Judy (1922-1969). Women in World History: A Biographical Encyclopedia (Gale) supports
Milestones, Jun. 27, 1969 supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Sedative, hypnotic, or anxiolytic use disorder (barbiturate), moderate, with physiological dependence; began with sleeping pills given in adolescence; synthetic modern episode linked to her documented lifelong dependence on prescribed sleeping pills active confirmed both_with_link CLM-0003, CLM-0005
S Stimulant use disorder (prescribed amphetamine), mild; began with stimulants given in adolescence for weight and energy; synthetic modern episode linked to her documented pep pills active confirmed both_with_link CLM-0003, CLM-0005
S Chronic insomnia disorder, long-standing, with sleep tied to sleeping pills since adolescence active confirmed active CLM-0003
S Contraception three months after childbirth while starting an enzyme-inducing drug: injectable progestin chosen because barbiturates, including any used for the withdrawal, weaken contraceptive pills, patches, rings and implants active confirmed active CLM-0010
S Major depressive disorder, single episode, moderate, with anxious distress; Mood Disorder Questionnaire negative and no history of mania or hypomania active confirmed active
S Acute laryngitis, probably viral, during rehearsals, treated with voice rest and supportive care; resolved resolved confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 1955-06-22 Hemoglobin [Mass/volume] in Blood 12.3 g/dL
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 1955-06-22 MCV [Entitic mean volume] in Red Blood Cells by Automated count 86 fL
Reference 80-100 fL
http://loinc.org · 787-2
S 1955-06-22 Platelets [#/volume] in Blood by Automated count 284 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1955-06-22 Ferritin [Mass/volume] in Serum or Plasma 24 ng/mL
Reference 15-150 ng/mL
http://loinc.org · 2276-4
S 1955-06-22 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1955-06-22 Potassium [Moles/volume] in Serum or Plasma 4.1 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1955-06-22 Creatinine [Mass/volume] in Serum or Plasma 0.66 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 1955-06-22 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1950)/1.73 sq M 119 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1955-06-22 Glucose [Mass/volume] in Serum or Plasma 82 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 1955-06-22 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 21 U/L
Reference 10-35 U/L
http://loinc.org · 1920-8
S 1955-06-22 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 18 U/L
Reference 7-35 U/L
http://loinc.org · 1742-6
S 1955-06-22 Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma 24 U/L
Reference 5-40 U/L
http://loinc.org · 2324-2
S 1955-06-22 Thyrotropin [Units/volume] in Serum or Plasma 1.9 mIU/L
Reference 0.4-4.5 mIU/L
http://loinc.org · 3016-3
S 1955-06-22 Total score [DAST-10] 6 http://loinc.org · 82667-7
S 1955-06-22 Total score [AUDIT-C] 2 http://loinc.org · 75626-2
S 1955-06-22 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 14 http://loinc.org · 44261-6
S 1955-06-22 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 13 http://loinc.org · 70274-6
S 1955-07-20 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 12 http://loinc.org · 44261-6
S 1955-07-20 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 11 http://loinc.org · 70274-6
S 1955-08-31 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 9 http://loinc.org · 44261-6
S 1955-08-31 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 8 http://loinc.org · 70274-6
S 1955-09-28 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 7 http://loinc.org · 44261-6
S 1955-10-26 Hemoglobin [Mass/volume] in Blood 12.9 g/dL
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 1955-10-26 MCV [Entitic mean volume] in Red Blood Cells by Automated count 87 fL
Reference 80-100 fL
http://loinc.org · 787-2
S 1955-10-26 Platelets [#/volume] in Blood by Automated count 268 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1955-10-26 Ferritin [Mass/volume] in Serum or Plasma 41 ng/mL
Reference 15-150 ng/mL
http://loinc.org · 2276-4
S 1955-10-26 Sodium [Moles/volume] in Serum or Plasma 140 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1955-10-26 Potassium [Moles/volume] in Serum or Plasma 4.2 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1955-10-26 Creatinine [Mass/volume] in Serum or Plasma 0.68 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 1955-10-26 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1950)/1.73 sq M 118 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1955-10-26 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 23 U/L
Reference 10-35 U/L
http://loinc.org · 1920-8
S 1955-10-26 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 20 U/L
Reference 7-35 U/L
http://loinc.org · 1742-6
S 1955-10-26 Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma 48 U/L (high)
Reference 5-40 U/L
http://loinc.org · 2324-2
S 1955-10-26 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 5 http://loinc.org · 44261-6
S 1955-10-26 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 5 http://loinc.org · 70274-6

Synthetic vital signs

DateMeasureResultLOINCGrade
1955-06-22Body height151 cm8302-2S
1955-06-22Body weight46.5 kg29463-7S
1955-06-22Body mass index (BMI) [Ratio]20.4 kg/m239156-5S
1955-06-22Systolic blood pressure128 mm[Hg]8480-6S
1955-06-22Diastolic blood pressure84 mm[Hg]8462-4S
1955-06-22Heart rate98 /min8867-4S
1955-06-22Respiratory rate16 /min9279-1S
1955-06-22Body temperature36.8 Cel8310-5S
1955-06-22Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
1955-06-29Body height151 cm8302-2S
1955-06-29Body weight46.8 kg29463-7S
1955-06-29Body mass index (BMI) [Ratio]20.5 kg/m239156-5S
1955-06-29Systolic blood pressure124 mm[Hg]8480-6S
1955-06-29Diastolic blood pressure80 mm[Hg]8462-4S
1955-06-29Heart rate92 /min8867-4S
1955-06-29Respiratory rate16 /min9279-1S
1955-06-29Body temperature36.7 Cel8310-5S
1955-06-29Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
1955-07-20Body height151 cm8302-2S
1955-07-20Body weight47.6 kg29463-7S
1955-07-20Body mass index (BMI) [Ratio]20.9 kg/m239156-5S
1955-07-20Systolic blood pressure118 mm[Hg]8480-6S
1955-07-20Diastolic blood pressure76 mm[Hg]8462-4S
1955-07-20Heart rate82 /min8867-4S
1955-07-20Respiratory rate14 /min9279-1S
1955-07-20Body temperature36.6 Cel8310-5S
1955-07-20Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
1955-08-31Body height151 cm8302-2S
1955-08-31Body weight48.9 kg29463-7S
1955-08-31Body mass index (BMI) [Ratio]21.4 kg/m239156-5S
1955-08-31Systolic blood pressure112 mm[Hg]8480-6S
1955-08-31Diastolic blood pressure72 mm[Hg]8462-4S
1955-08-31Heart rate72 /min8867-4S
1955-08-31Respiratory rate14 /min9279-1S
1955-08-31Body temperature36.7 Cel8310-5S
1955-08-31Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
1955-10-26Body height151 cm8302-2S
1955-10-26Body weight50 kg29463-7S
1955-10-26Body mass index (BMI) [Ratio]21.9 kg/m239156-5S
1955-10-26Systolic blood pressure112 mm[Hg]8480-6S
1955-10-26Diastolic blood pressure70 mm[Hg]8462-4S
1955-10-26Heart rate68 /min8867-4S
1955-10-26Respiratory rate14 /min9279-1S
1955-10-26Body temperature36.6 Cel8310-5S
1955-10-26Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
1955-09-28Body height151 cm8302-2S
1955-09-28Body weight49.4 kg29463-7S
1955-09-28Body mass index (BMI) [Ratio]21.7 kg/m239156-5S
1955-09-28Systolic blood pressure110 mm[Hg]8480-6S
1955-09-28Diastolic blood pressure70 mm[Hg]8462-4S
1955-09-28Heart rate70 /min8867-4S
1955-09-28Respiratory rate14 /min9279-1S
1955-09-28Body temperature36.6 Cel8310-5S
1955-09-28Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
1955-08-17Body height151 cm8302-2S
1955-08-17Body weight48.4 kg29463-7S
1955-08-17Body mass index (BMI) [Ratio]21.2 kg/m239156-5S
1955-08-17Systolic blood pressure116 mm[Hg]8480-6S
1955-08-17Diastolic blood pressure74 mm[Hg]8462-4S
1955-08-17Heart rate84 /min8867-4S
1955-08-17Respiratory rate16 /min9279-1S
1955-08-17Body temperature37.6 Cel8310-5S
1955-08-17Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Structured safety assessment

Current ideation
absent
Intent
absent
Plan
absent
Disposition
Outpatient care with close follow-up. Risk factors reviewed without detail: past suicide attempts reported in earlier years, a sedative use disorder, depression, the months after childbirth, and the low mood that can follow stopping a stimulant. Barbiturates are dangerous in overdose, so means safety is part of the plan: she agreed to take the unused capsules from earlier prescriptions to a pharmacy take-back at the next visit, to keep the current supply in a locked box, and to receive no more than seven days at a time. No alcohol with the barbiturate. A written safety plan was made with her, and the 988 Suicide & Crisis Lifeline (call or text 988) was saved in her phone. Safety is reviewed at every visit

This assessment is synthetic and does not convert historical behavior into a present-day fact.

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

Care-plan goals

GoalTarget dateStatusOutcome
Change from secobarbital to phenobarbital under supervision without a withdrawal seizure or delirium1955-07-20completedFour-day supervised admission; no seizure, delirium or severe withdrawal
Lower the phenobarbital dose slowly, at no more than about 20% every two weeks, toward stopping1955-10-26active97.2 mg a day at discharge to 32.4 mg a day at four months; two pauses when needed; taper continuing
Stop dextroamphetamine with a short taper and no return to it1955-08-31completedStopped after a two-week taper; tiredness for about two weeks, then better
Sleep six hours or more on most nights using CBT for insomnia1955-10-26activeAbout six hours on most nights; rebound wakefulness after each dose step settles within a week
PHQ-9 below 5 by six months1955-10-26activePHQ-9 14 to 5 at four months; response
Regular meals and weight she is comfortable with, without dieting drugs1955-10-26completedThree meals on most days; weight up 3.5 kg to a BMI of 21.9; she says she feels stronger

Interventions

InterventionStatusGuideline
Safe prescribing of controlled drugs: one prescriber and one pharmacy, a prescription drug monitoring program check before every controlled-substance prescription, a written shared treatment agreement, urine drug testing explained as part of care, seven-day supplies at first, a locked box, and take-back of unused capsulescompletedGL-BZD-TAPER-2025, GL-CDC-PDMP
Addiction medicine consultation to confirm the diagnoses, plan a safe barbiturate withdrawal and taper, and advise on stopping the stimulantcompletedGL-BZD-TAPER-2025, GL-ASAM-AWM-2020, GL-ASAM-STIM-2024
Supervised barbiturate withdrawal: a short hospital admission to change secobarbital to phenobarbital with withdrawal scoring and seizure precautions, then a slow outpatient phenobarbital taper of no more than about 20% every two weeks, slower toward the end, paused for withdrawal symptoms, illness or a major performance, never stopped abruptly; no benzodiazepine or Z-drug in its place; no alcoholcompletedGL-BZD-TAPER-2025, GL-ASAM-AWM-2020
Stimulant: dextroamphetamine held at one fixed morning dose until phenobarbital is stable, then 5 mg for two weeks and stopped, with mood, sleep and appetite checks; no other stimulantcompletedGL-ASAM-STIM-2024
Insomnia: cognitive behavioral therapy for insomnia as first-line treatment, adapted to late performances (a fixed wake time, a wind-down routine after shows, sleep restriction only after the taper is stable), with a sleep diary; no new hypnoticcompletedGL-ACP-INSOMNIA-2016, GL-AASM-INSOMNIA-2017
Depression and anxiety: PHQ-9 and GAD-7 at each visit, sertraline, weekly psychotherapy, the Mood Disorder Questionnaire before the antidepressant, a structured safety assessment with a written safety plan, means safety and the 988 Suicide & Crisis Lifeline, and safety review at every visitcompletedGL-CMID-2026, GL-USPSTF-DEP-2023, GL-SUICIDE-2024
Nutrition and weight without stigma: regular meals and snacks around rehearsals, a dietitian visit, no weight-loss target and no dieting drugs, and screening for disordered eatingcompletedGL-ASAM-STIM-2024
Contraception that barbiturates do not weaken: medroxyprogesterone injection every 13 weeks, after a negative pregnancy test, with an intrauterine device as an alternativecompletedGL-CDC-MEC-2024
Naloxone not prescribed: she takes no opioid, has no opioid prescription in the monitoring program, her urine test shows no opioids or fentanyl, and all her pills come from a pharmacy; naloxone does not reverse a barbiturate overdose. To be offered at once if an opioid is ever prescribed or any pill comes from outside a pharmacycompletedGL-ASAM-STIM-2024, GL-CDC-PDMP
Work: taper steps scheduled away from major performances, a written plan for late nights and travel, and letters she controlscompletedGL-BZD-TAPER-2025

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Powers N. Garland, Judy (1922-1969). Women in World History: A Biographical Encyclopedia (Gale) Encyclopedia.com biography
SRC-0002 Milestones, Jun. 27, 1969 TIME other
SRC-0003 5 Interesting Facts About Judy Garland PBS American Masters (WNET) biography
SRC-0004 Haynes S. The True Story Behind Judy, the New Film Based on Judy Garland's Life TIME other
SRC-0005 Bertram C. Judy Garland Filmed The Wizard of Oz Under Grueling Conditions Biography.com (A&E Television Networks) other
SRC-0006 Blakemore E. Golden Age Hollywood Had a Dirty Little Secret: Drugs History.com (A&E Television Networks) other
SRC-0007 Bertram C. Inside Judy Garland's Final Years and Her London Concerts Biography.com (A&E Television Networks) other
SRC-0008 Review of Clarke G. Get Happy: The Life of Judy Garland Kirkus Reviews other
SRC-0009 Review of Clarke G. Get Happy: The Life of Judy Garland Publishers Weekly other
SRC-0010 TV Guide, Philadelphia edition, September 24, 1955 (Media History Digital Library) Lantern, Media History Digital Library primary
SRC-0011 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the DSM-5-TR criteria count that excludes tolerance and withdrawal, the secobarbital to phenobarbital conversion and the admission, the taper pace (the 2025 benzodiazepine guideline applied by analogy, since it excludes barbiturates), the order of the stimulant taper, sertraline with phenobarbital, the contraception choice with an enzyme inducer, and the decision not to prescribe naloxone.
provenance reviewnot_startedSources: Women in World History (Encyclopedia.com), TIME (1969 and 2019), PBS American Masters, Biography.com (two articles), History.com, Kirkus Reviews and Publishers Weekly reviews of Gerald Clarke's biography, and TV Guide (1955) through the Media History Digital Library. The biography itself was not read. Who first gave her pills is graded R and disputed.
safe messaging reviewnot_startedSubstance use and mental health claims are marked sensitive; past suicide attempts and hospital stays are recorded without detail; her death is recorded once in one plain sentence; person-first language; the pills given to her as a minor are presented as harm done to her, not her fault; the safety assessment gives the 988 Suicide & Crisis Lifeline and addresses means safety. No living relative is named.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.